arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

LABCORP HOLDINGS INC.

LH
$304.06 ▼ -7.35 (-2.36%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
72 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Neutral
auto_awesome

Analytical Summary

LABCORP HOLDINGS INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $24.8B
Dividend Yield 0.24%
Revenue Growth 5.8%
Op. Margin 12.1%
ROIC 2.5%
FCF / Share $3.84
Trailing P/E 83.1x
Price / Book 2.9x
FCF Yield 1.3%
Debt / Equity 0.68
info Valuation on last close. End-of-day price, Sep 23, 2026.

72-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.73B
↑ +5.8%
Net Income Profit after all expenses
$277.80M
↑ +30.5%
Operating Margin Operating profit as % of sales
12.1%
↑ +12.4% 56th
FCF / Share Free cash flow per share
$3.84
↑ +348.5%
Long-Term Debt Long-term obligations
$5.86B
— +0.4%

Health Breakdown

Profitability
56
Returns
68
Financial Health
61
Cash Quality
78

Dividend History

Dividend / share · sourced from SEC filings
$2.88 Latest / share
+0.0% YoY
+0.0% 3-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 19 years · 72 quarters